Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Neill

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Human Mutation|July 24, 2013
Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delaysAndrey Shuvarikov, Ian M Campbell, Piotr Dittwald, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Cancer Discovery|August 28, 2024
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast CancerJitendra K Meena, Jarey H Wang, Nicholas J Neill, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
Human Mutation|February 1, 2012
Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic featuresAllen N Lamb, Jill A Rosenfeld, Nicholas J Neill, et al.
Cancer Discovery|August 8, 2025
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancerNicholas J Neill, Shankha Satpathy, Karsten Krug, et al.
American Journal of Human Genetics|January 22, 2013
Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminusGea Beunders, Els Voorhoeve, Christelle Golzio, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Human Mutation|July 24, 2013
Recurrent HERV-H-mediated 3q13.2-q13.31 deletions cause a syndrome of hypotonia and motor, language, and cognitive delaysAndrey Shuvarikov, Ian M Campbell, Piotr Dittwald, et al.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
American Journal of Medical Genetics. Part A|March 16, 2013
Investigation of NRXN1 deletions: clinical and molecular characterizationMindy Preston Dabell, Jill A Rosenfeld, Patricia Bader, et al.
Cancer Discovery|August 28, 2024
MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast CancerJitendra K Meena, Jarey H Wang, Nicholas J Neill, et al.
Cell|January 15, 2021
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerElizabeth A Bowling, Jarey H Wang, Fade Gong, et al.
Human Mutation|February 1, 2012
Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic featuresAllen N Lamb, Jill A Rosenfeld, Nicholas J Neill, et al.
Cancer Discovery|August 8, 2025
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancerNicholas J Neill, Shankha Satpathy, Karsten Krug, et al.
American Journal of Human Genetics|January 22, 2013
Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminusGea Beunders, Els Voorhoeve, Christelle Golzio, et al.
Pageof 2